Baseline Substance Use Interferes with Maintenance of HIV Medication Adherence Skills

Sannisha Dale, Lara Traeger, Conall O'Cleirigh, C. Andres Bedoya, Megan Pinkston, Julianne G. Wilner, Michael Stein, Steven Safren

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV improves both adherence and depression outcomes relative to enhanced treatment as usual (ETAU). However, in persons with injection drug use (PWIDU) histories, adherence gains seen during treatment have not been maintained postintervention. Therefore, we examined whether heroin or cocaine use at study entry moderated acquisition or maintenance of adherence gains after CBT-AD. HIV-positive adults in treatment for opioid dependence (n = 89) were randomly assigned to CBT-AD or ETAU and completed 3-, 6-, and 12-month assessments. Participants were majority male (61%), white (48%), and heterosexual (79%). Hierarchical linear modeling was used to evaluate whether heroin or cocaine use at baseline interacted with intervention assignment to predict change in adherence during active treatment and follow-up. CBT-AD-related improvement in adherence during the active intervention period did not vary by baseline substance use. However, cocaine use (but not heroin use) at baseline interacted with intervention assignment to predict a significant decline in follow-up adherence (cocaine use × group condition coefficient = -0.77, t = -2.44, p = 0.02) such that by 12 months, adherence among CBT participants was significantly lower among those who used cocaine (45.0%) compared to those who did not (72.3%; t = 2.50, p = 0.018). HIV-positive PWIDU who use heroin or cocaine at baseline can benefit from the CBT-AD intervention to improve adherence to antiretroviral therapy; therefore, providers should not withhold an active psychosocial treatment for HIV-positive PWIDU who are using. Cocaine use at baseline may limit the degree to which gains are maintained postintervention, and therefore, booster sessions may be needed.

Original languageEnglish (US)
Pages (from-to)215-220
Number of pages6
JournalAIDS Patient Care and STDs
Volume30
Issue number5
DOIs
StatePublished - May 1 2016

Fingerprint

Medication Adherence
Cocaine
Cognitive Therapy
Maintenance
HIV
Heroin
Depression
Therapeutics
Injections
Pharmaceutical Preparations
Heterosexuality
Opioid Analgesics

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Baseline Substance Use Interferes with Maintenance of HIV Medication Adherence Skills. / Dale, Sannisha; Traeger, Lara; O'Cleirigh, Conall; Bedoya, C. Andres; Pinkston, Megan; Wilner, Julianne G.; Stein, Michael; Safren, Steven.

In: AIDS Patient Care and STDs, Vol. 30, No. 5, 01.05.2016, p. 215-220.

Research output: Contribution to journalArticle

Dale, S, Traeger, L, O'Cleirigh, C, Bedoya, CA, Pinkston, M, Wilner, JG, Stein, M & Safren, S 2016, 'Baseline Substance Use Interferes with Maintenance of HIV Medication Adherence Skills', AIDS Patient Care and STDs, vol. 30, no. 5, pp. 215-220. https://doi.org/10.1089/apc.2015.0340
Dale, Sannisha ; Traeger, Lara ; O'Cleirigh, Conall ; Bedoya, C. Andres ; Pinkston, Megan ; Wilner, Julianne G. ; Stein, Michael ; Safren, Steven. / Baseline Substance Use Interferes with Maintenance of HIV Medication Adherence Skills. In: AIDS Patient Care and STDs. 2016 ; Vol. 30, No. 5. pp. 215-220.
@article{ca9e855aa08a4478af0d6090479623d6,
title = "Baseline Substance Use Interferes with Maintenance of HIV Medication Adherence Skills",
abstract = "Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV improves both adherence and depression outcomes relative to enhanced treatment as usual (ETAU). However, in persons with injection drug use (PWIDU) histories, adherence gains seen during treatment have not been maintained postintervention. Therefore, we examined whether heroin or cocaine use at study entry moderated acquisition or maintenance of adherence gains after CBT-AD. HIV-positive adults in treatment for opioid dependence (n = 89) were randomly assigned to CBT-AD or ETAU and completed 3-, 6-, and 12-month assessments. Participants were majority male (61{\%}), white (48{\%}), and heterosexual (79{\%}). Hierarchical linear modeling was used to evaluate whether heroin or cocaine use at baseline interacted with intervention assignment to predict change in adherence during active treatment and follow-up. CBT-AD-related improvement in adherence during the active intervention period did not vary by baseline substance use. However, cocaine use (but not heroin use) at baseline interacted with intervention assignment to predict a significant decline in follow-up adherence (cocaine use × group condition coefficient = -0.77, t = -2.44, p = 0.02) such that by 12 months, adherence among CBT participants was significantly lower among those who used cocaine (45.0{\%}) compared to those who did not (72.3{\%}; t = 2.50, p = 0.018). HIV-positive PWIDU who use heroin or cocaine at baseline can benefit from the CBT-AD intervention to improve adherence to antiretroviral therapy; therefore, providers should not withhold an active psychosocial treatment for HIV-positive PWIDU who are using. Cocaine use at baseline may limit the degree to which gains are maintained postintervention, and therefore, booster sessions may be needed.",
author = "Sannisha Dale and Lara Traeger and Conall O'Cleirigh and Bedoya, {C. Andres} and Megan Pinkston and Wilner, {Julianne G.} and Michael Stein and Steven Safren",
year = "2016",
month = "5",
day = "1",
doi = "10.1089/apc.2015.0340",
language = "English (US)",
volume = "30",
pages = "215--220",
journal = "AIDS Patient Care and STDs",
issn = "1087-2914",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Baseline Substance Use Interferes with Maintenance of HIV Medication Adherence Skills

AU - Dale, Sannisha

AU - Traeger, Lara

AU - O'Cleirigh, Conall

AU - Bedoya, C. Andres

AU - Pinkston, Megan

AU - Wilner, Julianne G.

AU - Stein, Michael

AU - Safren, Steven

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV improves both adherence and depression outcomes relative to enhanced treatment as usual (ETAU). However, in persons with injection drug use (PWIDU) histories, adherence gains seen during treatment have not been maintained postintervention. Therefore, we examined whether heroin or cocaine use at study entry moderated acquisition or maintenance of adherence gains after CBT-AD. HIV-positive adults in treatment for opioid dependence (n = 89) were randomly assigned to CBT-AD or ETAU and completed 3-, 6-, and 12-month assessments. Participants were majority male (61%), white (48%), and heterosexual (79%). Hierarchical linear modeling was used to evaluate whether heroin or cocaine use at baseline interacted with intervention assignment to predict change in adherence during active treatment and follow-up. CBT-AD-related improvement in adherence during the active intervention period did not vary by baseline substance use. However, cocaine use (but not heroin use) at baseline interacted with intervention assignment to predict a significant decline in follow-up adherence (cocaine use × group condition coefficient = -0.77, t = -2.44, p = 0.02) such that by 12 months, adherence among CBT participants was significantly lower among those who used cocaine (45.0%) compared to those who did not (72.3%; t = 2.50, p = 0.018). HIV-positive PWIDU who use heroin or cocaine at baseline can benefit from the CBT-AD intervention to improve adherence to antiretroviral therapy; therefore, providers should not withhold an active psychosocial treatment for HIV-positive PWIDU who are using. Cocaine use at baseline may limit the degree to which gains are maintained postintervention, and therefore, booster sessions may be needed.

AB - Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV improves both adherence and depression outcomes relative to enhanced treatment as usual (ETAU). However, in persons with injection drug use (PWIDU) histories, adherence gains seen during treatment have not been maintained postintervention. Therefore, we examined whether heroin or cocaine use at study entry moderated acquisition or maintenance of adherence gains after CBT-AD. HIV-positive adults in treatment for opioid dependence (n = 89) were randomly assigned to CBT-AD or ETAU and completed 3-, 6-, and 12-month assessments. Participants were majority male (61%), white (48%), and heterosexual (79%). Hierarchical linear modeling was used to evaluate whether heroin or cocaine use at baseline interacted with intervention assignment to predict change in adherence during active treatment and follow-up. CBT-AD-related improvement in adherence during the active intervention period did not vary by baseline substance use. However, cocaine use (but not heroin use) at baseline interacted with intervention assignment to predict a significant decline in follow-up adherence (cocaine use × group condition coefficient = -0.77, t = -2.44, p = 0.02) such that by 12 months, adherence among CBT participants was significantly lower among those who used cocaine (45.0%) compared to those who did not (72.3%; t = 2.50, p = 0.018). HIV-positive PWIDU who use heroin or cocaine at baseline can benefit from the CBT-AD intervention to improve adherence to antiretroviral therapy; therefore, providers should not withhold an active psychosocial treatment for HIV-positive PWIDU who are using. Cocaine use at baseline may limit the degree to which gains are maintained postintervention, and therefore, booster sessions may be needed.

UR - http://www.scopus.com/inward/record.url?scp=84969551360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969551360&partnerID=8YFLogxK

U2 - 10.1089/apc.2015.0340

DO - 10.1089/apc.2015.0340

M3 - Article

C2 - 27158849

AN - SCOPUS:84969551360

VL - 30

SP - 215

EP - 220

JO - AIDS Patient Care and STDs

JF - AIDS Patient Care and STDs

SN - 1087-2914

IS - 5

ER -